| Literature DB >> 27182419 |
Abstract
The purpose of the study was to determine if measured maximal heart rate (HRmax) was affected by sex or aerobic training status, and to determine the accuracy of three common clinical age-prediction maximal heart rate regression equations used to predict HRmax: HRmax= 220 - age, HRmax= 226 - age, and HRmax= 208 - (0.7 · age). Fifty-two participants in total, 30 of which were in the active group (15 M, 15 F) and 22 subjects in the sedentary group (9 M, 13 F), within the age range of 18-25 years and with a normal BMI (18.5-24.9 kg·m-2) underwent a Bruce maximal treadmill exercise protocol. The effect of sex and training status on HRmax was analyzed through a two-way ANOVA, and the effect of sex, aerobic training status, and regression equation on accuracy of the HRmax prediction was assessed with a three-way ANOVA (α=0.05). Overall, males had a higher HRmax than females (198.3 v. 190.4 beats • min-1, p<.001) and sedentary individuals had higher measured HRmax than active individuals (197.3 v. 191.4 beats • min-1, p=.002). Furthermore, HRmax= 208 - (0.7 · age)(equation 3) calculated the smallest signed and unsigned residuals from the difference between observed HRmax and predicted HRmax values for the significant main effects of equation (3), equation × sex (females × 3), and equation × activity level (active × 3). Therefore, based on our results, we conclude that HRmax= 208 - (0.7 · age) has greater accuracy than the other two equations studied for predicting observed values of HRmax in 18-25 year olds.Entities:
Keywords: Maximal heart rate; active; age; female; inactive; male; maximal heart rate prediction equations
Year: 2015 PMID: 27182419 PMCID: PMC4831892
Source DB: PubMed Journal: Int J Exerc Sci ISSN: 1939-795X
Demographic one-way ANOVA between groups, significance determined by Tukey HSD post hoc.
| P | Act. Males | Sed. Males | Act. Females | Sed. Females | |
|---|---|---|---|---|---|
| Age (yr) | 0.2 | 21.4 ± 1.7 | 21.8 ± 2.6 | 20.1 ± 2.3 | 20.9 ± 1.9 |
| Height (m) | 0 | 1.80 ± 0.060 | 1.77 ± 0.059 | 1.64 ± 0.048 | 1.61 ± 0.067 |
| Mass (kg) | 0 | 76 ± 6 | 67.1 ± 6.9 | 61.2 ± 6.1 | 54.7 ± 5.5 |
| BMI (kg·m−2) | 0.003 | 23.5 ± 1.8 | 21.4 ± 1.2 | 22.8 ± 1.8 | 21.2 ± 2 |
Values are mean ± SE.
Significance for sex of same training group (male vs female), P < 0.05.
Significance for training group of same sex (active vs sedentary), P < 0.05.
Significance for opposing sex + opposing training group, P < 0.05.
Descriptive independent and dependent variables one-way ANOVA between groups, significance determined by Tukey HSD post hoc.
| F | P | Act. Males | Sed. Males | Act. Females | Sed. Females | |
|---|---|---|---|---|---|---|
| Walking (min·wk−1) | 5.7 | 0.002 | 339.5 ± 338.8 | 138.9 ± 117.3 | 409 ± 413.6 | 91.0 ± 80.1 |
| Moderate (min·wk−1) | 2.5 | 0.069 | 119.3 ± 178.0 | 17.8 ± 39.3 | 82.7 ± 121.7 | 11.5 ± 28.8 |
| Vigorous (min·wk−1) | 10.3 | 0 | 188 ± 171.5 | 0 ± 0 | 148 ± 101.3 | 3.5 ± 12.5 |
|
| ||||||
|
| ||||||
| HRrest (beats·min−1) | 5.9 | 0.002 | 70.5 ± 7.1 | 86.0 ± 10.0 | 72.3 ± 10.2 | 76.7 ± 9.6 |
| HRmax (beats·min−1) | 8.6 | 0 | 194.5 ± 5.8 | 202.1 ± 8.3 | 188.3 ± 6.2 | 192.5 ± 6.5 |
| VO2max [(ml·kg−1)·min−1] | 26.9 | 0 | 55.6 ± 8.14 | 42.6 ± 4.19 | 41.6 ± 6.54 | 34.6 ± 4.81 |
| RER | 4.3 | 0.009 | 1.16 ± 0.05 | 1.25 ± 0.08 | 1.20 ± 0.05 | 1.26 ± 0.12 |
Values are mean ± SE.
Significance is based on square root transformation
Significance for sex of same training group (male vs female), P < 0.05.
Significance for training group of same sex (active vs sedentary), P < 0.05.
Significance for opposing sex + opposing training group, P < 0.05.
Differences in measure HRmax between sex and activity using two-way ANOVA.
| SEX | ACTIVITY LEVEL | ||
|---|---|---|---|
| Male | Female | Active | Sedentary |
| 198.3 ± 1.4 | 190.4 ± 1.2 | 191.4 ± 1.2 | 197.3 ± 1.4 |
Values are mean ± SE.
Significant main effect for sex, P < .05.
Significant main effect for activity level, P < 0.05.
Signed and unsigned raw residuals using three-way ANOVA, P-values are based on Huynh-Feldt adjustment.
| SIGNED | F | P | UNSIGNED | F | P | ||
|---|---|---|---|---|---|---|---|
| Male | −0.3 ± 1.4 | 22.2 | 0 | 7.6 ± 0.9 | 4.45 | 0.04 | |
| Female | −9.1 ± 1.3 | 10.3 ± 0.8 | |||||
|
| |||||||
| Active (Act.) | −7.9 ± 1.2 | 11.9 | 0.001 | 9.4 ± 0.8 | 0.49 | 0.49 | |
| Sedentary (Sed.) | −1.5 ± 1.4 | 8.5 ± 1.0 | |||||
|
| |||||||
| 220 - age (1) | −4.6 ± 1.0 | 1.3E4 | 0 | 8.0 ± 0.8 | 30.1 | 0 | |
| 226 - age (2) | −10.6 ± 1.0 | 12.0 ± 0.8 | |||||
| 208 - (0.7 · age) (3) | 1.1 ± 0.9 | 6.8 ± 0.6 | |||||
|
| |||||||
| Act. Male | −4.3 ± 1.7 | 0.64 | 0.43 | 6.6 ± 1.1 | 5.16 | 0.03 | |
| Sed. Male | 3.7 ± 2.2 | 8.6 ± 1.5 | |||||
| Act. Female | −11.6 ± 1.7 | 12.1 ± 1.1 | |||||
| Sed. Female | −6.6 ± 1.8 | 8.4 ± 1.2 | |||||
|
| |||||||
| Male × 1 | −0.1 ± 1.4 | 3.14 | 0.08 | 6.5 ± 1.1 | 14.8 | 0 | |
| Male × 2 | −6.1 ± 1.4 | 8.9 ± 1.2 | |||||
| Male × 3 | 5.4 ± 1.4 | 7.5 ± 1.0 | |||||
| Female × 1 | −9.1 ± 1.3 | 9.6 ± 1.0 | |||||
| Female × 2 | −15.1 ± 1.3 | 15.1 ± 1.1 | |||||
| Female × 3 | −3.2 ± 1.2 | 6.2 ± 0.9 | |||||
|
| |||||||
| Act. × 1 | −7.9 ± 1.2 | 0.95 | 0.34 | 8.4 ± 1.0 | 8.2 | 0.003 | |
| Act. × 2 | −13.9 ± 1.2 | 13.9 ± 1.1 | |||||
| Act. × 3 | −2.1 ± 1.2 | 5.9 ± 0.8 | |||||
| Sed. × 1 | −1.3 ± 1.5 | 7.7 ± 1.2 | |||||
| Sed. × 2 | −7.3 ± 1.5 | 10.1 ± 1.3 | |||||
| Sed. × 3 | 4.3 ± 1.4 | 7.8 ± 1.0 | |||||
|
| |||||||
| Act. Male × 1 | −4.1 ± 1.7 | 0.12 | 0.75 | 5.1 ± 1.4 | 1.9 | 0.17 | |
| Act. Male × 2 | −10.1 ± 1.7 | 10.1 ± 1.5 | |||||
| Act. Male × 3 | 1.5 ± 1.7 | 4.7 ± 1.2 | |||||
| Sed. Male × 1 | 3.9 ± 2.2 | 7.9 ± 1.8 | |||||
| Sed. Male × 2 | −2.1 ± 2.2 | 7.7 ± 2.0 | |||||
| Sed. Male × 3 | 9.4 ± 2.2 | 10.3 ± 1.5 | |||||
| Act. Female × 1 | −11.6 ± 1.7 | 11.7 ± 1.4 | |||||
| Act. Female × 2 | −17.6 ± 1.7 | 17.6 ± 1.5 | |||||
| Act. Female × 3 | −5.6 ± 1.7 | 5.1 ± 1.4 | |||||
| Sed. Female × 1 | −6.5 ± 1.9 | 10.1 ± 1.5 | |||||
| Sed. Female × 2 | −12.5 ± 1.9 | 4.7 ± 1.2 | |||||
| Sed. Female × 3 | −0.8 ± 1.8 | 7.9 ± 1.8 | |||||
Values are mean ± SE.
Significant main effect for signed raw residuals, P < 0.05.
Significant main effect for unsigned raw residuals, P < 0.05.